Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Trex Wind-Down Inc TMBRQ

Healthcare
Trex Wind-Down, Inc., formerly Timber Pharmaceuticals, Inc., has filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code and is winding down its business. The Company has no operation nor generates any revenue.

Recent & Breaking News (GREY:TMBRQ)

Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market

GlobeNewswire November 29, 2023

Timber Pharmaceuticals Receives Court Approval of All "First Day" Motions to Support Business Operations & Discloses Communication From NYSE American

GlobeNewswire November 28, 2023

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

GlobeNewswire September 18, 2023

TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR

Business Wire August 29, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Timber Pharmaceuticals, Inc. Buyout

Newsfile August 21, 2023

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, ESTE, PR, TMBR

PR Newswire August 21, 2023

TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders

Business Wire August 21, 2023

Timber Pharmaceuticals to be Acquired by LEO Pharma

GlobeNewswire August 21, 2023

Timber Pharmaceuticals Discloses Communication From NYSE American

GlobeNewswire July 3, 2023

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

GlobeNewswire June 20, 2023

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

GlobeNewswire June 5, 2023

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

GlobeNewswire May 15, 2023

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

GlobeNewswire March 31, 2023

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

GlobeNewswire March 20, 2023

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

GlobeNewswire February 24, 2023

Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward Outlook

GlobeNewswire December 14, 2022

Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

GlobeNewswire December 9, 2022

Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial Results

GlobeNewswire November 14, 2022

Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock Split

GlobeNewswire November 8, 2022

Timber Pharmaceuticals Announces Halt of Common Stock Trading  

GlobeNewswire November 3, 2022